F(ab')2 fragment

F(ab')2 fragment refers to a specific type of antibody fragment that is generated by the enzymatic cleavage of antibodies. This fragment is composed of two Fab fragments linked by disulfide bonds, without the Fc region that is found in full-length antibodies. The F(ab')2 fragment retains the ability to bind to antigens, making it useful in various biomedical research and clinical diagnostics applications.

Production

F(ab')2 fragments are typically produced by treating antibodies with enzymes such as pepsin. Pepsin cleaves the antibody molecule below the hinge region, removing the Fc portion and leaving behind a dimer of Fab fragments, which is the F(ab')2 fragment. This process can be controlled to ensure that the resulting fragments retain their antigen-binding sites and are free from the Fc region, which is responsible for effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and complement activation.

Applications

F(ab')2 fragments have several applications in both research and clinical settings:

• Immunohistochemistry (IHC): Due to their reduced size compared to full-length antibodies, F(ab')2 fragments can penetrate tissues more effectively, making them valuable for staining in IHC.
• Immunofluorescence: Similar to IHC, the improved tissue penetration and reduced non-specific binding due to the absence of the Fc region make F(ab')2 fragments useful in immunofluorescence assays.
• Reducing Non-Specific Binding: The absence of the Fc region in F(ab')2 fragments minimizes non-specific binding to Fc receptors on cells, reducing background noise in various assays.
• Therapeutic Applications: In some therapeutic contexts, the reduced potential for eliciting immune responses due to the absence of the Fc region can be advantageous. F(ab')2 fragments have been explored for their use in treating conditions where a reduced immune response is desired.

Advantages and Limitations

The primary advantage of F(ab')2 fragments is their ability to bind antigens without the involvement of the Fc region, which can reduce non-specific binding and immune activation. However, the absence of the Fc region also means that F(ab')2 fragments lack the effector functions mediated by this region, which can be a limitation in therapeutic contexts where such functions are desired.

Conclusion

F(ab')2 fragments represent a valuable tool in the arsenal of molecular biology and immunology, offering specific advantages over full-length antibodies in certain applications. Their production and use in research and clinical diagnostics highlight the ongoing importance of antibody fragments in advancing our understanding and treatment of diseases.

F(ab')2 fragment Resources
Latest articles Most recent articles Ongoing trials	Wikipedia